+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Uremic (Renal) Pruritus Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767932
  • Report
  • 56 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Acologix Inc.
  • Almirall SA
  • Cara Therapeutics Inc
  • DS BioPharma Ltd
  • Frenova LLC
  • GlaxoSmithKline Plc
  • MORE
The global clinical trial report- “2019 Uremic (Renal) Pruritus Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Uremic (Renal) Pruritus. It presents in-depth analysis of Uremic (Renal) Pruritus clinical trials across markets and companies. The research work is for providing complete understanding into trends in Uremic (Renal) Pruritus.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Uremic (Renal) Pruritus clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Uremic (Renal) Pruritus

The research work is prepared through extensive and continuous research on Uremic (Renal) Pruritus trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Uremic (Renal) Pruritus patients are identified
  • The report includes panorama of Uremic (Renal) Pruritus clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Uremic (Renal) Pruritus clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acologix Inc.
  • Almirall SA
  • Cara Therapeutics Inc
  • DS BioPharma Ltd
  • Frenova LLC
  • GlaxoSmithKline Plc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Uremic (Renal) Pruritus Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Uremic (Renal) Pruritus Clinical Trials by Region
2.2.2 Average Enrollment of Uremic (Renal) Pruritus Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Uremic (Renal) Pruritus Treatment, 2019

3. Region wise Uremic (Renal) Pruritus Clinical Trials
3.1 Asia Pacific Uremic (Renal) Pruritus Clinical Trials by Country
3.2 Europe Uremic (Renal) Pruritus Clinical Trials by Country
3.3 North America Uremic (Renal) Pruritus Clinical Trials by Country
3.4 Middle East and Africa Uremic (Renal) Pruritus Clinical Trials by Country
3.5 South and Central America Uremic (Renal) Pruritus Clinical Trials by Country

4. Uremic (Renal) Pruritus Clinical Trial Trends
4.1 Start Year wise Uremic (Renal) Pruritus Clinical Trials
4.2 Phase wise Uremic (Renal) Pruritus Clinical Trials
4.3 Trial Status wise Uremic (Renal) Pruritus Clinical Trials
4.4 Trial Type wise Uremic (Renal) Pruritus Clinical Trials

5. Uremic (Renal) Pruritus Average Enrollment Trends
5.1 Average Enrollment in Uremic (Renal) Pruritus Trials by Year
5.2 Average Enrollment in Uremic (Renal) Pruritus Trials by Phase
5.3 Average Enrollment in Uremic (Renal) Pruritus Trials by Status
5.4 Average Enrollment in Uremic (Renal) Pruritus Trials by Type of Trial

6. Companies Participating in Uremic (Renal) Pruritus Clinical Trials
6.1 Uremic (Renal) Pruritus Trials by Sponsor Type
6.2 Uremic (Renal) Pruritus Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Uremic (Renal) Pruritus Trials- Phase 1
7.2 Uremic (Renal) Pruritus Trials- Phase 2
7.3 Uremic (Renal) Pruritus Trials- Phase 3
7.4 Uremic (Renal) Pruritus Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Uremic (Renal) Pruritus Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Figure 5: Europe - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Figure 7: North America - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Figure 9: Uremic (Renal) Pruritus Clinical Trials by Phase
Figure 10: Uremic (Renal) Pruritus Clinical Trials by Trial Status
Figure 11: Uremic (Renal) Pruritus Clinical Trials by Type
Figure 12: Uremic (Renal) Pruritus Clinical Trials by Sponsor Type
Figure 13: Uremic (Renal) Pruritus Clinical Trials by Leading Sponsors
Figure 14: Uremic (Renal) Pruritus Average Enrollment by Phase
Figure 15: Uremic (Renal) Pruritus Average Enrollment by Trial Status
Figure 16: Uremic (Renal) Pruritus Average Enrollment by Type
Figure 17: Uremic (Renal) Pruritus- Average Enrolment by Type of Sponsors
Figure 18: Uremic (Renal) Pruritus- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Uremic (Renal) Pruritus Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Table 5: Europe - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Table 7: North America - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Uremic (Renal) Pruritus Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Uremic (Renal) Pruritus Average Enrollment by Phase
Table 15: Uremic (Renal) Pruritus Average Enrollment by Trial Status
Table 16: Uremic (Renal) Pruritus Average Enrollment by Type
Table 17: Uremic (Renal) Pruritus- Average Enrolment by Type of Sponsors
Table 18: Uremic (Renal) Pruritus- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acologix Inc.
  • Almirall SA
  • Cara Therapeutics Inc
  • DS BioPharma Ltd
  • Frenova LLC
  • GlaxoSmithKline Plc
  • Patara Pharma Inc
  • PSI CRO AG
  • Toray Industries Inc
  • Trevi Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll